Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?
Chronic liver diseases constitute a significant economic, social, and biomedical burden. Among commonly adopted approaches, only organ transplantation can radically help patients with end-stage liver pathologies. Cell therapy with hepatocytes as a treatment for chronic liver disease has demonstrated...
Main Authors: | Irina V. Kholodenko, Leonid K. Kurbatov, Roman V. Kholodenko, Garik V. Manukyan, Konstantin N. Yarygin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/10/1127 |
Similar Items
-
Resistance of Human Liver Mesenchymal Stem Cells to FAS-Induced Cell Death
by: Irina V. Kholodenko, et al.
Published: (2022-07-01) -
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
by: Irina V. Kholodenko, et al.
Published: (2023-10-01) -
Mesenchymal Stem Cell–Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope?
by: Zhu L, et al.
Published: (2024-01-01) -
Immunomodulatory Nature and Site Specific Affinity of Mesenchymal Stem Cells: a Hope in Cell Therapy
by: Parisa Lotfinegad, et al.
Published: (2014-03-01) -
Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools
by: Irina V. Kholodenko, et al.
Published: (2022-10-01)